Tag Archives: RESI

Top 10 Casino Stocks To Watch Right Now

If there’s a stock perfect for the “Bro Investor” who likes risk, action, and (potentially) a big pay-off, it’s DraftKings (NASDAQ:DKNG).

Source: Tada Images / Shutterstock.com

DraftKings began as a fantasy sports game manager. It took advantage of the 2018 Supreme Court decision allowing the legalization of sports gambling to build an empire.

On August 12 that empire was worth $21 billion. The stock opened for trade at about $52.20 per share. Caesar’s Entertainment (NYSE:CZR), the largest physical casino operator, is worth $19.8 billion.....More>>>

Best Clean Energy Stocks To Own For 2023

Chris Johnson

In the markets, just like in life, sometimes it pays to hold off on pulling that trigger – however tough that might be.

Good things come to those who wait… The waiting is the hardest part… Do not open till Xmas…

Today’s penny stock pick is the perfect example – and I’ll tell you why in a second.

By now, you know I’m super bullish on the clean energy stocks, along with fellow travelers in “clean tech,” like the battery industry, lithium and rare earths, electric vehicles, and so on.

When....More>>>

Top 10 Medical Stocks To Invest In 2019

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €107.00 ($124.42) price target from equities researchers at HSBC in a note issued to investors on Tuesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.04% from the stock’s current price.

FME has been the subject of several other reports. JPMorgan Chase & Co. set a €96.10 ($111.74) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday,....More>>>

Best Heal Care Stocks To Buy For 2019

Mirati Therapeutics (NASDAQ:MRTX) had its price target lifted by analysts at MED to $1.78 in a research note issued on Tuesday. The brokerage currently has a “buy” rating on the biotechnology company’s stock. MED’s price target indicates a potential downside of 96.54% from the company’s current price.

A number of other brokerages have also commented on MRTX. Cann upped their target price on Mirati Therapeutics from $35.00 to $62.00 and gave the company an “average” rating in a research note on Monday, July 9th. BidaskClub lowered Mirati Therapeutics....More>>>

Top 10 Value Stocks To Own Right Now

Ride-sharing app Uber appears to excel in how to be in the news for all the wrong reasons. Earlier this year, the company was accused of turning a blind eye to sexual harassment in the office. Later on, there was a viral video showing its CEO Travis Kalanick berating an Uber driver. Then, this week, it landed in more trouble when it was sued over one of its app features that tracks drivers. But despite the negative publicity, Uber continues to remain one of the highest valued privately held companies and the market continues to await its IPO.

Ubers Financials

But first the numbers.....More>>>